Biohaven Pharmaceutical Holding Company Ltd (NYSE:BHVN)

148.10
Delayed Data
As of 3:59pm ET
 +0.06 / +0.04%
Today’s Change
79.01
Today|||52-Week Range
151.51
+7.47%
Year-to-Date
Top 5 2nd Quarter Trades of CARLSON CAPITAL L P
Aug 16 / GuruFocus News - Paid Partner Content
Top 5 2nd Quarter Trades of Paul Tudor Jones
Aug 15 / GuruFocus News - Paid Partner Content
Top 5 2nd Quarter Trades of HARVEST MANAGEMENT LLC
Aug 15 / GuruFocus News - Paid Partner Content
BARDIN HILL MANAGEMENT PARTNERS LP Buys 3, Sells 2 in 2nd Quarter
Aug 14 / GuruFocus News - Paid Partner Content
EVENTIDE ASSET MANAGEMENT, LLC Buys 1, Sells 4 in 2nd Quarter
Aug 15 / GuruFocus News - Paid Partner Content
Top 5 2nd Quarter Trades of GABELLI FUNDS LLC
Aug 14 / GuruFocus News - Paid Partner Content
ADAGE CAPITAL PARTNERS GP, L.L.C. Goes on Buying Spree in 2nd Quarter
Aug 15 / GuruFocus News - Paid Partner Content
Biohaven Pharmaceutical (BHVN) Q2 Earnings Lag, Sales Beat
Aug 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close148.04
Today’s open148.03
Day’s range148.00 - 148.24
Volume328,379
Average volume (3 months)1,417,281
Market cap$10.6B
Data as of 3:59pm ET, 08/19/2022

Growth & Valuation

Earnings growth (last year)-0.26%
Earnings growth (this year)+5.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+626.91%
P/E ratioNM
Price/Sales19.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+1.02+0.46%
JAZZJazz Pharmaceuticals...+0.16+0.10%
SRPTSarepta Therapeutics...-0.80-0.74%
----
Data as of 4:00pm ET, 08/19/2022

Financials

Next reporting dateNovember 8, 2022
EPS forecast (this quarter)-$2.11
Annual revenue (last year)$462.5M
Annual profit (last year)-$846.6M
Net profit margin-183.04%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New Haven, Connecticut

Forecasts